The AntifolatesVISENTIN, Michele; RONGBAO ZHAO; GOLDMAN, I. David et al.Hematology/oncology clinics of North America. 2012, Vol 26, Num 3, issn 0889-8588, ix, 629-648 [21 p.]Article

Pemetrexed (ALIMTA), a novel multitargeted antineoplastic agentADJEI, Alex A.Clinical cancer research. 2004, Vol 10, Num 12, pp 4276s-4280s, issn 1078-0432, 2Conference Paper

Méthotrexate = MethotrexateCAPPELAERE, P; ARMAND, J.-P.Gazette médicale de France (1969). 1986, pp 15-16, issn 0016-5557, suppl. no 42Article

Intoxication grave au méthotrexateTROCHE, G; SACQUIN, P; ACHKAR, A et al.La Presse médicale (1983). 1991, Vol 20, Num 35, pp 1724-1727, issn 0755-4982Article

Ode to methotrexateBERTINO, J. R.Journal of clinical oncology. 1993, Vol 11, Num 1, pp 5-14, issn 0732-183XArticle

5-Amino-4-lmidazolecarboxamide riboside potentiates both transport of reduced folates and antifolates by the human reduced folate carrier and their subsequent metabolismMCGUIRE, John J; HAILE, William H; YEH, Chen-Chen et al.Cancer research (Baltimore). 2006, Vol 66, Num 7, pp 3836-3844, issn 0008-5472, 9 p.Article

Synergistic interaction between methotrexate and a superoxide dismutase mimetic : Pharmacologic and potential clinical significanceCUZZOCREA, Salvatore; MAZZON, Emanuela; DI PAOLA, Rosanna et al.Arthritis and rheumatism. 2005, Vol 52, Num 12, pp 3755-3760, issn 0004-3591, 6 p.Article

Structural features of 4-amino antifolates required for substrate activity with mammalian folylpolyglutamate synthetaseMORAN, R. G; COLMAN, P. D; ROSOWSKY, A et al.Molecular pharmacology. 1985, Vol 27, Num 1, pp 156-166, issn 0026-895XArticle

Les stratégies d'utilisation du méthotrexateWENDLING, Daniel.Rhumatos. 2010, Vol 7, Num 60, pp 2-4, issn 1771-0081, 3 p., CAH2Article

Antifolate resistance in a HeLa cell line associated with impaired transport independent of the reduced folate carrierRONGBAO ZHAO; CHATTOPADHYAY, Shrikanta; HANSCOM, Marie et al.Clinical cancer research. 2004, Vol 10, Num 24, pp 8735-8742, issn 1078-0432, 8 p.Article

The renewed potential for folate antagonists in contemporary cancer chemotherapyBERMAN, E. M; WERBEL, L. M.Journal of medicinal chemistry (Print). 1991, Vol 34, Num 2, pp 479-485, issn 0022-2623, 7 p.Article

Anticancer drug development at Lilly Research Laboratories. DiscussionPEARCE, H. L; HART, I.Annals of oncology. 1995, Vol 6, pp S55-S62, issn 0923-7534, SUP1Conference Paper

An investigation into the source of the deglutamated metabolites of methotrexate in patients treated with high dose infusionsSTEWART, M. J; WATSON, I. D; FARID, Y. Y. Z et al.Annals of clinical biochemistry. 1986, Vol 23, Num 2, pp 210-215, issn 0004-5632Article

2,4-diaminopteridine-based compounds as precursors for de novo synthesis of antifolates : a novel class of antimalarialsNDUATI, Eunice; HUNT, Sonya; KAMAU, Eddy M et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 9, pp 3652-3657, issn 0066-4804, 6 p.Article

Éléments prédictifs de la réponse thérapeutique au méthotrexateCANTAGREL, Alain.Revue du rhumatisme (Ed. française). 2010, Vol 77, pp 4-9, issn 1169-8330, 6 p., HS1Article

Initiative 3 E: Evidence, Expertise, ExchangeWENDLING, Daniel.Rhumatos. 2010, Vol 7, Num 58, pp 5-6, issn 1771-0081, 2 p., CAH3Article

Methotrexate for psoriasis in the era of biological therapyWARREN, R. B; CHALMERS, R. J. G; GRIFFITHS, C. E. M et al.Clinical and experimental dermatology (Print). 2008, Vol 33, Num 5, pp 551-554, issn 0307-6938, 4 p.Article

Foie et méthotrexate = The liver and methotrexateLAHANE, D; TERREBONNE, E; VERGNIOL, J et al.Gastroentérologie clinique et biologique. 2008, Vol 32, Num 2, pp 134-142, issn 0399-8320, 9 p.Article

Early identification of resistance to first-line single-agent methotrexate in patients with persistent trophoblastic diseaseVAN TROMMEL, Nienke E; MASSUGER, Leon F; SCHIJF, Charles P et al.Journal of clinical oncology. 2006, Vol 24, Num 1, pp 52-58, issn 0732-183X, 7 p.Article

ABCG2 harboring the Gly482 mutation confers high-level resistance to various hydrophilic antifolatesSHAFRAN, Assaf; IFERGAN, Ilan; BRAM, Eran et al.Cancer research (Baltimore). 2005, Vol 65, Num 18, pp 8414-8422, issn 0008-5472, 9 p.Article

Anomalies associated with failed methotrexate and misoprostol terminationYEDLINSKY, Nicole T; MORGAN, Frank C; WHITECAR, Paul W et al.Obstetrics and gynecology (New York. 1953). 2005, Vol 105, Num 5, pp 1203-1205, issn 0029-7844, 3 p., 2Article

Antifolate activity of epigallocatechin gallate against Stenotrophomonas maltophiliaNAVARRO-MARTINEZ, Maria Dolores; NAVARRO-PERAN, Enma; CABEZAS-HERRERA, Juan et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 7, pp 2914-2920, issn 0066-4804, 7 p.Article

The role of α-folate receptor-mediated transport in the antitumor activity of antifolate drugsTHETI, Davinder S; JACKMAN, Ann L.Clinical cancer research. 2004, Vol 10, Num 3, pp 1080-1089, issn 1078-0432, 10 p.Article

A rapid and sensitive method for determination of trimetrexate from biological fluidsACKERLY, C. C; HARTSHORN, J; TONG, W. P et al.Journal of liquid chromatography. 1985, Vol 8, Num 1, pp 125-134, issn 0148-3919Article

Bilateral subdural hygromas following intrathecal methotrexateLOKIREDDY, Padmaja; DYER, Martin J. S.British journal of haematology. 2011, Vol 155, Num 5, issn 0007-1048, p. 536Article